{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:30:05Z","timestamp":1777620605894,"version":"3.51.4"},"reference-count":20,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,10,22]],"date-time":"2008-10-22T00:00:00Z","timestamp":1224633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> It is questionable whether a symptomatic condition with few serious medical consequences requires proton pump inhibitor (PPI) treatment. If effective, a less\u2010potent treatment may be preferable.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To compare an H2\u2010blocker in an effervescent formulation with a PPI in on\u2010demand treatment of endoscopy\u2010negative gastro\u2010oesophageal reflux disease (GERD).<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Included were patients with heartburn and\/or acid regurgitation for at least 3\u2003months duration, a negative endoscopy and a positive response to 7\u2003days of lansoprazole 60\u2003mg daily. Following pH\u2010metry, the patients were randomized to receive either ranitidine effervescent tablets 75\u2003mg or lansoprazole capsules 15\u2003mg to a maximum of four per day on\u2010demand. The numbers taken were registered monthly for 6\u2003months. If treatment was unsuccessful (lack of efficacy or side effects), patients were registered as failures.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> One hundred and three patients were included and 63 were considered for statistical analysis; 32 on lansoprazole and 31 on ranitidine. Seventeen (55%) on ranitidine and four (13%) on lansoprazole failed. The average number of tablets per day was 1.2 in the lansoprazole group and 3.1 in the ranitidine group.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> On\u2010demand treatment in patients with endoscopy\u2010negative GERD gives a high success rate with a fairly low dose of PPI. The H2\u2010blocker had significantly less success; nevertheless, almost half were satisfied with the treatment.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2008.03877.x","type":"journal-article","created":{"date-parts":[[2008,12,19]],"date-time":"2008-12-19T00:07:30Z","timestamp":1229645250000},"page":"207-212","source":"Crossref","is-referenced-by-count":15,"title":["On\u2010demand requirements of patients with endoscopy\u2010negative gastro\u2010oesophageal reflux disease: H2\u2010blocker vs. proton pump inhibitor"],"prefix":"10.1111","volume":"29","author":[{"given":"P.","family":"JUUL\u2010HANSEN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"RYDNING","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,12,16]]},"reference":[{"issue":"2","key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2036.1997.tb00798.x","article-title":"Endoscopy\u2010negative reflux disease","volume":"11","author":"Smout AJPM","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/10.1.9"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.2008.S1"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.3109\/13814789509161628"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1572-0241.1999.1123_a.x","article-title":"Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology","volume":"94","author":"DeVault KR","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709011212"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000139033.30945.7f"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00681.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520701561959"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.24.2947"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01275.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.9.950"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00403.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.300000.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310006432"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520212499"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00564.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200208000-00008"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00943.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00384.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2008.03877.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2008.03877.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T18:29:00Z","timestamp":1697221740000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2008.03877.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,16]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1111\/j.1365-2036.2008.03877.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2008.03877.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,16]]}}}